blood clots and glp 1 GLP-1 meds might reduce clot risk in diabetes patients Can Mounjaro Cause Blood Clots?

What are the primary off-label uses for Ozempic

Hershko, C., Pinson, A

Common adverse effects include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation

In the DUAL V, 40% of patients assuming Liraglutide/Degludec received 50 dose steps after 26 weeks corresponding to 1.8 mg of Liraglutide, with a wide range of variability also depending on baseline BMI (65)

A separate analysis of the STEP 1 data found that lean mass was reduced by 6.92 kg with a total weight reduction of 15.3 kg, meaning roughly 45 percent of the weight lost was lean mass

Mean FVC, FEV 1 , and FEV 1 /FVC were 3.94L (75.44%), 2.22L (58.50%), and 0.53